Related Experiment Video
Updated: Sep 28, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Insights
The 2022 Guideline for the Management of Heart Failure offers updated, patient-centered recommendations for preventing, diagnosing, and treating heart failure, based on the latest evidence. This comprehensive guideline aims to improve care quality for heart failure patients globally.
Area of Science:
- Cardiology
- Clinical Practice Guidelines
Background:
- Heart failure is a major global cause of illness and death.
- Previous guidelines from 2013 and 2017 have been superseded.
- The guideline focuses on patient-centered care.
Framework:
- Provides evidence-based recommendations for heart failure management.
- Incorporates contemporary research and clinical trial data.
- Harmonized with other major American Heart Association/American College of Cardiology guidelines.
Implementation:
- Literature search conducted May-December 2020, with updates through September 2021.
- Includes studies, reviews, and evidence on human subjects.
- Utilizes multiple databases including MEDLINE (PubMed) and EMBASE.
Implications:
- Aims to enhance the quality of care for heart failure patients.
- Aligns clinical practice with patients' best interests.
- Introduces new recommendations and updates existing ones based on new evidence.
Aim:
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.
Methods:
A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.
Structure:
Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology

